Eyeonix AIQ, Inc.
No SEC Form 4 filings for $EAIQ in the last 30 days.
See all $EAIQ insider activity →Eyeonix AIQ (EAIQ) announced the addition of Dr. Rohit Chitale and Dr. Grigoris Gerotziafas to its board of directors, effective October 16, 2026. The company did not disclose reasons or committee changes.
Eyeonix AIQ, Inc. (EAIQ) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 16, 2026 The Company added Dr. Rohit Chitale and Dr. Grigoris Gerotziafas to the board of directors in an Extrao
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning EAIQ (Eyeonix AIQ, Inc.). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.
Recent EAIQ coverage spans financial news and corporate actions.
Board appointments are unlikely to move the stock in the short term.
Board expansion with two new directors; no immediate financial impact disclosed.
AlphAI scores every news story that mentions EAIQ with an AI model for sentiment and relevance, and aggregates insider trades from Eyeonix AIQ, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Eyeonix AIQ (EAIQ) announced the addition of Dr. Rohit Chitale and Dr. Grigoris Gerotziafas to its board of directors, effective October 16, 2026. The company did not disclose reasons or committee changes.
1 min readEyeonix AIQ, Inc. (EAIQ) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 16, 2026 The Company added Dr. Rohit Chitale and Dr. Grigoris Gerotziafas to the board of directors in an Extrao
1 min read
